Home
Conditions
Pneumococcal Infections

Clinical trial condition

Pneumococcal Infections

Explore clinical trials studying Pneumococcal Infections. Study availability and eligibility vary by location and protocol.

275 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Pneumococcal Infections trial results

Completed

Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

NCT01307449

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: Hope Clinic of the Emory Vaccine Center Decatur, Georgia, United States

Atlanta VA Medical Center Decatur, Georgia, United States

View Trial Details

Completed

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

NCT01153893

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Ikeja / Lagos, Nigeria

View Trial Details

Completed

Booster and Catch-up Vaccination With Vaccine GSK1024850A

NCT01030822

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Kolkata, India

GSK Investigational Site Ludhiana, India

GSK Investigational Site Pune, India

GSK Investigational Site Vellore, India

View Trial Details

Completed

Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine

NCT00911144

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Ansan, South Korea

GSK Investigational Site Bucheon-Si, GyeongGi-do,, South Korea

GSK Investigational Site Daejeon, South Korea

GSK Investigational Site Gyeonggi-do, South Korea

View all 14 locations

View Trial Details

Completed

Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children

NCT00950833

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Brno, Czechia

GSK Investigational Site Hradec Králové, Czechia

GSK Investigational Site Jindřichův Hradec, Czechia

GSK Investigational Site Náchod, Czechia

View Trial Details

Completed

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

NCT02955160

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: New Haven Clinical Research Unit New Haven, Connecticut, United States

View Trial Details

Completed

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects

NCT01531322

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: Pfizer Investigational Site Huaian, Jiangsu, China

Pfizer Investigational Site Nanjing, Jiangsu, China

View Trial Details

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

NCT00808444

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Kuala Lumpur, Malaysia

GSK Investigational Site Seremban, Negeri Sembilan, Malaysia

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

NCT00829010

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations: GSK Investigational Site Soweto, Gauteng, South Africa

View Trial Details

Completed

Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine

NCT03552445

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: Not specified

View Trial Details

Pneumococcal Infections

Pneumococcal Infections trial results

Related conditions